malondialdehyde has been researched along with Conus Medullaris Syndrome in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hosseini, M; Janzadeh, A; Karami, Z; Nasirinezhad, F; Yousefifard, M; Zarepour, L | 1 |
| Fu, Z; Hu, X; Jin, C; Liu, X; Wu, Y; Zhu, T | 1 |
| Bi, YL; Cao, Y; Fan, ZK; Li, G; Wang, YF; Wang, ZD; Yu, DS | 1 |
| Baykal, S; Cakir, E; Karahan, SC; Kuzeyli, K; Uydu, H | 1 |
| Cardali, S; Conti, A; Di Paola, R; Genovese, T; La Rosa, G | 1 |
| Demirhindi, H; Erman, T; Göçer, AI; Tuna, M; Yildiz, MS; Zorludemir, S | 1 |
| Alver, A; Arslan, E; Baykal, S; Cakir, E; Peksoylu, B; Sayin, OC; Topbas, M; Usul, H | 1 |
| Bramanti, P; Cuzzocrea, S; Di Bella, P; Di Paola, R; Esposito, E; Genovese, T; Mazzon, E; Muià, C | 1 |
| Gris, D; Hamilton, EF; Weaver, LC | 1 |
| Börcek, AO; Börcek, P; Cemil, B; Ceviker, N; Ergün, E; Gülbahar, O; Kurt, G | 1 |
| Belce, A; Ciplak, N; Gümüştaş, K; Hanci, M; Kafadar, A; Kaynar, MY | 1 |
| Akdemir, H; Karakücük, EI; Koc, RK; Menkü, A; Oktem, IS | 1 |
12 other study(ies) available for malondialdehyde and Conus Medullaris Syndrome
| Article | Year |
|---|---|
The role of CGRP receptor antagonist (CGRP8-37) and Endomorphin-1 combination therapy on neuropathic pain alleviation and expression of Sigma-1 receptors and antioxidants in rats.
Topics: Analgesics, Opioid; Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Disease Models, Animal; Drug Therapy, Combination; Glutathione Peroxidase; Hyperalgesia; Male; Malondialdehyde; Neuralgia; Oligopeptides; Pain Measurement; Pain Threshold; Peptide Fragments; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Spinal Cord; Spinal Cord Compression; Superoxide Dismutase; Treatment Outcome | 2020 |
Neuroprotective effect of hydrogen sulfide on acute cauda equina injury in rats.
Topics: Animals; Cauda Equina; Gasotransmitters; Glutathione; Hydrogen Sulfide; In Situ Nick-End Labeling; Laminectomy; Male; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Spinal Cord Compression; Sulfides | 2016 |
Neuroprotective effect of baicalin on compression spinal cord injury in rats.
Topics: Analysis of Variance; Animals; Apoptosis; Blood-Brain Barrier; Blotting, Western; Body Water; Flavonoids; Glutathione; Immunohistochemistry; Male; Malondialdehyde; Motor Activity; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Permeability; Rats; Rats, Sprague-Dawley; Recovery of Function; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord; Spinal Cord Compression; Tumor Necrosis Factor-alpha | 2010 |
Acute phase effects of ATP-MgCl2 on experimental spinal cord injury.
Topics: Acute-Phase Reaction; Adenosine Triphosphate; Animals; Disease Models, Animal; Lipid Peroxidation; Malondialdehyde; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Compression; Spinal Cord Injuries; Time Factors | 2003 |
Role of inflammation in the secondary injury following experimental spinal cord trauma.
Topics: Animals; Blotting, Western; Cytoplasm; Disease Models, Animal; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; NF-kappa B; Peroxidase; Protein Transport; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Compression | 2003 |
Effects of antithrombin III on myeloperoxidase activity, superoxide dismutase activity, and malondialdehyde levels and histopathological findings after spinal cord injury in the rat.
Topics: Animals; Antithrombin III; Disease Models, Animal; Male; Malondialdehyde; Peroxidase; Rats; Rats, Wistar; Spinal Cord Compression; Spinal Cord Injuries; Superoxide Dismutase | 2005 |
Effects of clotrimazole on experimental spinal cord injury.
Topics: Animals; Anti-Infective Agents, Local; Clotrimazole; Disease Models, Animal; Drug Evaluation, Preclinical; Malondialdehyde; Rats; Rats, Wistar; Spinal Cord Compression | 2006 |
Role of endogenous glutathione in the secondary damage in experimental spinal cord injury in mice.
Topics: Animals; Antimetabolites; Apoptosis; bcl-2-Associated X Protein; Buthionine Sulfoximine; DNA; Glutathione; Immunohistochemistry; In Situ Nick-End Labeling; Kinetics; Lipid Peroxidation; Male; Malondialdehyde; Mice; Neutrophil Infiltration; Peroxidase; Poly Adenosine Diphosphate Ribose; RNA; Spinal Cord Compression; Spinal Cord Injuries; Tyrosine | 2007 |
The systemic inflammatory response after spinal cord injury damages lungs and kidneys.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Disease Progression; Flow Cytometry; Inflammation; Kidney; Lipid Peroxidation; Lung; Macrophages; Male; Malondialdehyde; Matrix Metalloproteinase 9; Neutrophils; Peroxidase; Rats; Rats, Wistar; Spinal Cord Compression; Thiobarbituric Acid Reactive Substances; Time Factors | 2008 |
Neuroprotective effects of infliximab in experimental spinal cord injury.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Biomarkers; Disease Models, Animal; Infliximab; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Methylprednisolone; Neuroprotective Agents; Rats; Rats, Wistar; Recovery of Function; Spinal Cord Compression; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2009 |
The effect of duration of compression on lipid peroxidation after experimental spinal cord injury.
Topics: Animals; Female; Malondialdehyde; Rats; Rats, Sprague-Dawley; Spinal Cord Compression; Time Factors | 1998 |
Effect of methylprednisolone, tirilazad mesylate and vitamin E on lipid peroxidation after experimental spinal cord injury.
Topics: Animals; Antioxidants; Blood Pressure; Lipid Peroxidation; Male; Malondialdehyde; Methylprednisolone; Pregnatrienes; Rats; Spinal Cord Compression; Vitamin E | 1999 |